Magellan Health (MGLN) Reports Q4 EPS Loss of ($0.77), Revenues Miss; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Mid-Point Views Below Estimates

Magellan Health Reports Fourth Quarter and Full Year 2018 Financial Results

February 28, 2019 6:30 AM EST

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and full year ended December 31, 2018, as summarized below:

Three Months Ended Years Ended December 31 December 31 (In millions, except per share results)

2018

2017

Chg

2018

2017

Chg

Net revenue $ 1,844.6 $ 1,694.4 8.9 % $ 7,314.2 $ 5,838.6 25.3 % Net income (loss) $ (28.0 ) $ 54.5 -151.3 % $ 24.2 $ 110.2... More